Regulatory UpdatesSep 22, 2026•1 min read

FDA Approves ANDA088010 for Chlordiazepoxide Hydrochloride Capsule

By the PharmaCountry team

FDA granted approval (status AP) for VANGARD's ANDA088010 covering a 10 mg oral capsule of chlordiazepoxide hydrochloride, listed as discontinued.

The U.S. Food and Drug Administration (FDA) has issued an approval (status AP) for an Abbreviated New Drug Application (ANDA) numbered ANDA088010. The application, submitted by VANGARD, covers an oral capsule dosage form of chlordiazepoxide hydrochloride 10 mg (product number 001). The product is marked as discontinued and is not a reference drug. The original submission (type ORIG) was filed on March 28, 1983.

Compiled by the PharmaCountry team · Source: FDA.gov

Topics:#ANDA #FDA #chlordiazepoxide #oral capsule #generic drug #regulatory